Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Neurotech International Ltd. Appoints Associate Professor Carolyn Ellaway As Chief Medical Officer

PRIVATEJul 04, 2024•almost 2 years ago

Position

Chief Medical Officer

Company

Neurotech International Ltd

Carolyn Ellaway
NedlandsBiotechnologyHealth Care

Description

Neurotech International Ltd. has appointed Associate Professor Carolyn Ellaway as its new Chief Medical Officer, effective from August 1, 2024. A/Prof Ellaway will lead regulatory and clinical trial strategies for NTI164, a promising drug for pediatric neurological disorders.

Company Information

Company

Neurotech International Ltd

Location

Nedlands, Western Australia, Australia

About

Neurotech International Ltd. is a company focused on developing promising drugs for pediatric neurological disorders, such as Autism Spectrum Disorder and Rett Syndrome.

Predictive Intelligence
Strategic

ML-powered predictions for Neurotech International Ltd's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.